[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BowTiedBiotech π§ͺπ¬π§¬ [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.7K followers Created: 2025-07-05 18:19:53 UTC ποΈ New Episode: Your Weekly Biotech News Fix | Ep. XXX π£ποΈ TODAYβS PODCAST: [ 0:00 ] Intro [ 1:28 ] Regeneron BiFx Approval [ 3:33 ] Cosentyx GCA Trial Failure [ 6:05 ] Vyvgart Hytrulo Safety Risk [ 7:30 ] Argenx Macrocyclic Peptide Deal [ 10:17 ] Gilead HIV Market Strategy [ 12:02 ] Bluebird PE Acquisition [ 13:42 ] Sage Tx Buyout Drama [ 15:29 ] Beckley Psychedelic Nasal Spray [ 17:20 ] Mifepristone Access Debate [ 20:12 ] Closing π links to podcast: Substa*ck Spot!fy:  XXXXX engagements  **Related Topics** [acquisition](/topic/acquisition) [$argx](/topic/$argx) [intro](/topic/intro) [Post Link](https://x.com/BowTiedBiotech/status/1941562695628841260)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BowTiedBiotech π§ͺπ¬π§¬ @BowTiedBiotech on x 19.7K followers
Created: 2025-07-05 18:19:53 UTC
ποΈ New Episode: Your Weekly Biotech News Fix | Ep. XXX
π£ποΈ TODAYβS PODCAST: [ 0:00 ] Intro [ 1:28 ] Regeneron BiFx Approval [ 3:33 ] Cosentyx GCA Trial Failure [ 6:05 ] Vyvgart Hytrulo Safety Risk [ 7:30 ] Argenx Macrocyclic Peptide Deal [ 10:17 ] Gilead HIV Market Strategy [ 12:02 ] Bluebird PE Acquisition [ 13:42 ] Sage Tx Buyout Drama [ 15:29 ] Beckley Psychedelic Nasal Spray [ 17:20 ] Mifepristone Access Debate [ 20:12 ] Closing
π links to podcast: Substa*ck
Spot!fy:
XXXXX engagements
Related Topics acquisition $argx intro
/post/tweet::1941562695628841260